Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 4, 2022Bone Marrow TransplantationOpen Access

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older

View Full Paper
Ask AI
Bookmark
Share

Authors

DBDonata BackhausUniversity Hospital LeipzigDBDominic BrauerUniversity Hospital LeipzigRPRosmarie Pointner

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Backhaus et al. (2022) studied this question.

synapsesocial.com/papers/6a17cb3e3275b64d0e6f20cdhttps://doi.org/10.1038/s41409-022-01833-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1‘Mini‐allografts’ for haematological malignancies: an alternative to conventional myeloablative marrow transplantation1999 · 13 citations
  2. 2A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk1988 · 5,031 citations
  3. 3Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation2017 · 1,253 citations
  4. 4Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome2010 · 490 citations
  5. 5Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases2003 · 457 citations